Orziban Rizatriptan 5mg ODT 6Tabs
Oral tablets designed for the rapid relief of acute migraine attacks. The tablet dissolves quickly on the tongue, ensuring fast absorption and effective relief. It works by selectively stimulating serotonin 5-HT₁B/₁D receptors, leading to constriction of intracranial blood vessels and inhibition of inflammatory neuropeptide release, which helps relieve migraine pain and associated symptoms.
Indications:
- Used for the treatment of acute migraine attacks, with or without aura.
- Not intended for the prevention of migraine headaches or the management of hemiplegic or basilar migraine.
Main Active Ingredients:
- Rizatriptan 5 mg.
Precautions:
- Use only after confirming the diagnosis of migraine.
- Avoid use in patients with uncontrolled hypertension, ischemic heart disease, or cerebrovascular disorders.
- Not recommended for patients with severe hepatic or renal impairment.
- Should not be used within 24 hours of taking another triptan or ergotamine-containing medication.
- Use caution when driving or operating machinery due to possible drowsiness or dizziness.
- Not recommended for use during pregnancy or breastfeeding without medical advice.
Side Effects:
- Dizziness.
- Fatigue.
- Dry mouth.
- Nausea.
- Chest discomfort or tightness.
- Somnolence.
Drug–Drug Interactions:
- Contraindicated with monoamine oxidase inhibitors such as Phenelzine, Tranylcypromine, or Isocarboxazid.
- Caution when used with selective serotonin reuptake inhibitors such as Fluoxetine, Paroxetine, or Sertraline, serotonin–norepinephrine reuptake inhibitors such as Venlafaxine or Duloxetine, or tricyclic antidepressants such as Amitriptyline or Clomipramine.
- Avoid concurrent use with other triptans such as Sumatriptan or Zolmitriptan, or with ergotamine-containing medications such as Ergotamine or Dihydroergotamine.
- May interact with Propranolol, requiring dose adjustment of Rizatriptan.
Indications:
- Used for the treatment of acute migraine attacks, with or without aura.
- Not intended for the prevention of migraine headaches or the management of hemiplegic or basilar migraine.
Main Active Ingredients:
- Rizatriptan 5 mg.
Precautions:
- Use only after confirming the diagnosis of migraine.
- Avoid use in patients with uncontrolled hypertension, ischemic heart disease, or cerebrovascular disorders.
- Not recommended for patients with severe hepatic or renal impairment.
- Should not be used within 24 hours of taking another triptan or ergotamine-containing medication.
- Use caution when driving or operating machinery due to possible drowsiness or dizziness.
- Not recommended for use during pregnancy or breastfeeding without medical advice.
Side Effects:
- Dizziness.
- Fatigue.
- Dry mouth.
- Nausea.
- Chest discomfort or tightness.
- Somnolence.
Drug–Drug Interactions:
- Contraindicated with monoamine oxidase inhibitors such as Phenelzine, Tranylcypromine, or Isocarboxazid.
- Caution when used with selective serotonin reuptake inhibitors such as Fluoxetine, Paroxetine, or Sertraline, serotonin–norepinephrine reuptake inhibitors such as Venlafaxine or Duloxetine, or tricyclic antidepressants such as Amitriptyline or Clomipramine.
- Avoid concurrent use with other triptans such as Sumatriptan or Zolmitriptan, or with ergotamine-containing medications such as Ergotamine or Dihydroergotamine.
- May interact with Propranolol, requiring dose adjustment of Rizatriptan.
$2.83
Original: $9.44
-70%Orziban Rizatriptan 5mg ODT 6Tabs—
$9.44
$2.83Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
Oral tablets designed for the rapid relief of acute migraine attacks. The tablet dissolves quickly on the tongue, ensuring fast absorption and effective relief. It works by selectively stimulating serotonin 5-HT₁B/₁D receptors, leading to constriction of intracranial blood vessels and inhibition of inflammatory neuropeptide release, which helps relieve migraine pain and associated symptoms.
Indications:
- Used for the treatment of acute migraine attacks, with or without aura.
- Not intended for the prevention of migraine headaches or the management of hemiplegic or basilar migraine.
Main Active Ingredients:
- Rizatriptan 5 mg.
Precautions:
- Use only after confirming the diagnosis of migraine.
- Avoid use in patients with uncontrolled hypertension, ischemic heart disease, or cerebrovascular disorders.
- Not recommended for patients with severe hepatic or renal impairment.
- Should not be used within 24 hours of taking another triptan or ergotamine-containing medication.
- Use caution when driving or operating machinery due to possible drowsiness or dizziness.
- Not recommended for use during pregnancy or breastfeeding without medical advice.
Side Effects:
- Dizziness.
- Fatigue.
- Dry mouth.
- Nausea.
- Chest discomfort or tightness.
- Somnolence.
Drug–Drug Interactions:
- Contraindicated with monoamine oxidase inhibitors such as Phenelzine, Tranylcypromine, or Isocarboxazid.
- Caution when used with selective serotonin reuptake inhibitors such as Fluoxetine, Paroxetine, or Sertraline, serotonin–norepinephrine reuptake inhibitors such as Venlafaxine or Duloxetine, or tricyclic antidepressants such as Amitriptyline or Clomipramine.
- Avoid concurrent use with other triptans such as Sumatriptan or Zolmitriptan, or with ergotamine-containing medications such as Ergotamine or Dihydroergotamine.
- May interact with Propranolol, requiring dose adjustment of Rizatriptan.
Indications:
- Used for the treatment of acute migraine attacks, with or without aura.
- Not intended for the prevention of migraine headaches or the management of hemiplegic or basilar migraine.
Main Active Ingredients:
- Rizatriptan 5 mg.
Precautions:
- Use only after confirming the diagnosis of migraine.
- Avoid use in patients with uncontrolled hypertension, ischemic heart disease, or cerebrovascular disorders.
- Not recommended for patients with severe hepatic or renal impairment.
- Should not be used within 24 hours of taking another triptan or ergotamine-containing medication.
- Use caution when driving or operating machinery due to possible drowsiness or dizziness.
- Not recommended for use during pregnancy or breastfeeding without medical advice.
Side Effects:
- Dizziness.
- Fatigue.
- Dry mouth.
- Nausea.
- Chest discomfort or tightness.
- Somnolence.
Drug–Drug Interactions:
- Contraindicated with monoamine oxidase inhibitors such as Phenelzine, Tranylcypromine, or Isocarboxazid.
- Caution when used with selective serotonin reuptake inhibitors such as Fluoxetine, Paroxetine, or Sertraline, serotonin–norepinephrine reuptake inhibitors such as Venlafaxine or Duloxetine, or tricyclic antidepressants such as Amitriptyline or Clomipramine.
- Avoid concurrent use with other triptans such as Sumatriptan or Zolmitriptan, or with ergotamine-containing medications such as Ergotamine or Dihydroergotamine.
- May interact with Propranolol, requiring dose adjustment of Rizatriptan.
